Preventive Use of Common Antibiotic Reduces Child Mortality in Sub-Saharan Africa
Treating young children in Sub-Saharan Africa with azithromycin, a safe, inexpensive, and widely used antibiotic, significantly reduced deaths of children under five.
University of California San Francisco
Give to UCSFTreating young children in Sub-Saharan Africa with azithromycin, a safe, inexpensive, and widely used antibiotic, significantly reduced deaths of children under five.
A new study from UCSF shows preterm labor may sometimes happen when the fetal immune system “wakes up” too early and begins to reject the mother, causing the uterus to start contracting.
A newly launched Lancet Commission on Malaria Eradication will convene experts from around the world to develop the first-ever roadmap to eradicate malaria.
Sending community health workers door-to-door to look for sick kids in a rapidly urbanizing area of West Africa, and offering them free care, coincided with a dramatic drop in childhood mortality.
UCSF scientists have uncovered new mechanisms by which HIV hides in infected cells, resting in a latent state that evades the body’s immune system and preventing antiviral drugs from flushing it out.
The MEI is part of a group of partners that has been awarded a new contract by USAID to support the President’s Malaria Initiative’s Advancing the Progress of Malaria Service Delivery project in 28 countries.
A new UCSF study has shown that a cancer-killing (“oncolytic”) virus currently in clinical trials may function as a cancer vaccine.
An international team of researchers has shown that two different compounds, can safely and effectively be added to treatment regimens to block transmission of the most common form of malaria in Africa.
A new study shows that an immune signal named interleukin 33 plays a crucial role in allowing the brain to maintain the optimal number of synapses during the development of the central nervous system.
Children with an extremely deadly form of brain cancer might benefit from a new treatment that aims to direct an immune response against a mutant form of a protein found exclusively on cancer cells.
UCSF researchers are leading several initiatives that aim to see how dozens of seemingly unrelated genes and proteins involved in a disease are in fact all part the same interconnected biological pathway.
Joe DeRisi, PhD, a master detective of infectious diseases, stumbled on a clue to cracking the decades-long search for the place – or creature – where the Ebola virus hides between deadly outbreaks.
UCSF has ranked in the top 10 for seven specialties in 2017 Best Global Universities rankings released Tuesday by U.S. News & World Report.
UCSF Health Informatics team has used electronic health records to track down a source of a common hospital-acquired infection.
UCSF scientists have successfully completed a Phase II clinical trial showing that an FDA-approved antihistamine restores nervous system function in patients with chronic MS.